4th Helsinki HPV Workshop

Helsinki HPV symposium 2012

On January 12th, 2012 the University of Tampere and Helsinki, the Family Federation Finland and the Finnish Medical Association co-organised the 4th Helsinki HPV Workshop on Vaccinating Women and Men against Premature Death. The topic of the workshop was “Human Papillomavirus vaccination: safety, sound efficacy and public health effectiveness” and many of the Coheahr consortium partners presented their earlier work (related to the PreHdict project) during this workshop.
A summary of the symposium was published in HPV Today, number 32/33, December 2014.

 

PROGRAM

SAFETY OF HUMAN PAPILLOMAVIRUS VACCINATION AT THE POPULATION LEVEL

 

Daniel Weinberger (Harvard): Strain replacement following vaccination:
the example of pneumococcus
https://www.youtube.com/watch?v=LdpBDZlHnqc

 

Marko Merikukka (THL): No type-replacement following HPV vaccination
https://www.youtube.com/watch?v=tcd4nVPiibs

 

Sholom Wacholder (NCI): Safety of HPV vaccination based on adverse
effect reporting https://www.youtube.com/watch?v=qhweuk4E3YU

 

Jorma Paavonen (HUS): Safety of HPV vaccination compared to cervical
screening https://www.youtube.com/watch?v=Y3wAzBv-W6I

 

 

EFFICACY OF HPV VACCINATION AGAINST THE MOST STRINGENT END-POINTS

 

Dan Apter (FFF): Efficacy of HPV vaccination in males
https://www.youtube.com/watch?v=vVDlTeEgZPw

 

Kevin Ault (Emory): Efficacy of HPV vaccination against the stringent
end-points https://www.youtube.com/watch?v=c1ZznRkLrRs

 

Allan Hildesheim (NCI): Choice of outcome for post-licensure HPV
vaccine studies
https://www.youtube.com/watch?v=SfWQ0M-elg8

 

Joakim Dillner (KI): Monitoring efficacy of HPV-vaccination
https://www.youtube.com/watch?v=A3hzgKrafQk

 

 

EFFECTIVENESS AND IMPACT OF DIFFERENT HPV VACCINATION AND SCREENING
STRATEGIES

 

Marion Saville (Melbourne): Impact of 5-year school-based vaccination
of early adolescents https://www.youtube.com/watch?v=upuDrVdRc8U

 

Pekka Nieminen (HUS): Impact of organized primary HPV-screening
https://www.youtube.com/watch?v=WLqSFHcYQLA

 

Iacopo Baussano (ICL/IARC)      Modelling screening of HPV vaccinated
birth cohorts
https://www.youtube.com/watch?v=euITlmaR_wo

 

Matti Lehtinen (UTA)    Assessing the effectiveness of different
vaccination strategies
https://www.youtube.com/watch?v=7PTsQnIBNr4

 

Lutz Gissmann (DKFZ)    Human papillomavirus vaccines for developing countries
https://www.youtube.com/watch?v=PEVzjU317X8

 

Marc Arbyn (WIV-ISP)    Implementing HPV-disease control in the
developing countries
https://www.youtube.com/watch?v=Uvgvck6wy8Y

 

 

Charite=Charite University, Berlin, DKFZ=Deutsches
Krebsforschungsentrum, Emory=Emory University, FFF=Family Federation
Finland, IARC=International Agency for Research on Cancer,
ICL=Imperial College London, Harvard=Harvard University, KI=Karolinska
Institute, McGill=McGill University Montreal, Melbourne=Victorian
Cytology Service, Melbourne University, NCI=National Cancer Institute,
WIV-ISP=Sceintific Institute of Public Health, Brussels